Increases in the prices of cheap medicines, which were announced at the end of July, come into effect from today, with insured people being asked once again to dig deep into their pockets.
According to the list of the EMEA, there are increases of more than 1% for 843 formulations. In particular, for about 700 codes the increase is above 10% while 570 are increased by 20% and above.
In about 100 drugs the increase was by 100% while in one formulation the increase rate reached 448%. This is the biggest difference and it is a tyrothrin-based formulation (a dermatological antibiotic), which went from €0.96 to €5.26.
According to estimates, the total burden of expenditure from the new drug prices is estimated at about 90 million euros, 60 million euros of which will be covered by the EOPYY. The remaining approximately €30 million will be paid by the insured.
It is recalled that the pretext for the increases in 570 medicines was the fact that there were medicines sold at low prices in Greece compared to other European countries. This fact, according to the Ministry of Health, created a risk that these preparations would be withdrawn and cause an artificial shortage or replaced with newer and much more expensive ones.
Some examples:
- Stedon: EUR 9,95 from EUR 2,28
- Amoxil: EUR 4,81 from EUR 3,58
- Augmentin: EUR 7,48 from EUR 5,94
- Zovirax: EUR 8,45 from EUR 6,43
- Ceclor: EUR 7,06 from EUR 4,49
- Voltaren: EUR 3,32 from EUR 1,51
- Tavor: EUR 2,19 from EUR 1
- Lasix: EUR 2,7 from EUR 1,96
- Apotel: EUR 5,61 from EUR 3,85
- Salospir: EUR 2,08 from EUR 1,17
